Effect of renal impairment on the pharmacokinetics of prucalopride: a single- dose open-label Phase I study

OBJECTIVE: To evaluate the pharmacokinetics of prucalopride in individuals with renal impairment (RI). METHODS: This open-label Phase I study (ClinicalTrials.gov identifier: NCT01674192) enrolled men and women aged 18–75 years who were classified by renal function: normal renal function (creatinine...

Descripción completa

Detalles Bibliográficos
Autores principales: Smith, William B, Mannaert, Erik, Verhaeghe, Tom, Kerstens, René, Vandeplassche, Lieve, Van de Velde, Vera
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2012
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3529624/
https://www.ncbi.nlm.nih.gov/pubmed/23269861
http://dx.doi.org/10.2147/DDDT.S36142

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3529624/
https://www.ncbi.nlm.nih.gov/pubmed/23269861
http://dx.doi.org/10.2147/DDDT.S36142

Ejemplares similares